Go Pro
TSE:WEED

Canopy Growth Q4 2026 Earnings Report

Canopy Growth logo
C$1.38 -0.03 (-2.13%)
As of 12:32 PM Eastern

Canopy Growth EPS Results

Actual EPS
-C$0.40
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Canopy Growth Revenue Results

Actual Revenue
$71.25 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Canopy Growth Announcement Details

Quarter
Q4 2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Canopy Growth Earnings Headlines

The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel
Canopy Growth 4Q Loss Narrows, Revenue Rises
See More Canopy Growth Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Canopy Growth? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Canopy Growth and other key companies, straight to your email.

About Canopy Growth

Canopy Growth (TSE:WEED)oration, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

View Canopy Growth Profile